Nephros Inc.
Organization details
- Legal name
- Nephros Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South Orange
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NEPH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001196298
- EIN
- 13-3971809
Board of directors
-
Alisa Lask · DirectorSince 2023
-
Arthur H. Amron · DirectorSince 2023
-
Joseph Michael Harris · DirectorSince 2023
-
Lisa Marie Nettis · DirectorSince 2025
-
Oliver J. Spandow · DirectorSince 2023
-
Robert R. Banks Jr. · Director · President and CEOSince 2023
-
Tom Gwydir · DirectorSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
23.5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Director election results
Annual meeting of June 16, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.6%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Alisa Lask
- via Arthur H. Amron
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Arthur H. Amron Director | Other | +17,749 | — | — |
| Sep 14, 2026 | WEXFORD CAPITAL LP 10% owner | Other | −3,355,111 | — | — |
| Sep 14, 2026 | Arthur H. Amron Director | Other | +2,836 | — | — |
| Sep 14, 2026 | WEXFORD CAPITAL LP 10% owner | Other | −22,710 | $3.95 | $89,705 |
| Sep 14, 2026 | Arthur H. Amron Director | Other | +22,710 | $3.95 | $89,705 |
| Aug 18, 2026 | WEXFORD CAPITAL LP 10% owner | Option exercise | +812 | $3.60 | $2,923 |
| Aug 12, 2026 | Arthur H. Amron Director | Grant or award | +2,418 | — | — |
| May 11, 2026 | Arthur H. Amron Director | Grant or award | +3,574 | — | — |
| Mar 23, 2026 | Robert R. Banks Jr. Officer (President and CEO) | Option exercise | +120,000 | $1.44 | $172,800 |
| Mar 23, 2026 | Judy Krandel Officer (Chief Financial Officer) | Option exercise | +68,861 | $1.71 | $117,752 |
| Mar 16, 2026 | Arthur H. Amron Director | Grant or award | +3,610 | — | — |
| Nov 10, 2025 | Lisa Marie Nettis Director | Grant or award | +1,622 | — | — |
| Nov 10, 2025 | Oliver J. Spandow Director | Grant or award | +8,036 | — | — |
| Nov 10, 2025 | Arthur H. Amron Director | Grant or award | +5,391 | — | — |
| Jan 1, 2025 | Arthur H. Amron Director | Grant or award | +22,418 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.